Kailera Therapeutics (KLRA)

• Market cap: $2.19B
• 1 day: -0.65%
• 5 days: -6.41%
• 1 month: -23.1%
• 3 months: -32.24%
• 6 months: -34.85%
• Year to date: -34.85%
• 1 year: -34.85%
• 5 years: -34.85%
• 10 years: -34.85%
• Sector: Healthcare
• Industry: Biotechnology

About: Kailera Therapeutics Inc is a clinical-stage biotechnology company. The company focuses on developing a diversified pipeline to provide options for people living with obesity. The company is progressing four clinical-stage product candidates, leveraging multiple GLP-1 based mechanisms of action and routes of administration. The company's obesity-first approach seeks to advance product candidates with the potential to maximize weight loss and address critical needs in the current therapeutic landscape.